Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion type Assertion NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_head.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_provenance.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion evidence source_evidence_literature NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_provenance.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion SIO_000772 16507781 NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_provenance.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion wasDerivedFrom befree-2016 NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_provenance.
- NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_assertion wasGeneratedBy ECO_0000203 NP538060.RAaRGaB98h0_35obPxoAirwjYODt8Wf3xsxzNbaSf6oGs130_provenance.